Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination treatment of inflammatory bowel disease: Present status and future perspectives
John K. Triantafillidis, Constantinos G. Zografos, Manousos M. Konstadoulakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 15, pp. 2068-2080
Open Access | Times Cited: 19

Showing 19 citing articles:

Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 78-78
Open Access | Times Cited: 1
Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage Polarization
Alexandra Olate‐Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1616-1616
Open Access | Times Cited: 6
Intestinal permeability disturbances: causes, diseases and therapy
Barbara Macura, Aneta Kiecka, Marian Szczepanik
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease
Jeffrey A Lowell, Michael J. Farber, Keith Sultan
World Journal of Gastroenterology (2024) Vol. 30, Iss. 25, pp. 3182-3184
Open Access | Times Cited: 4
Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease
Yang Guo, Yan Xiong, Xueying Liu, et al.
World Journal of Nephrology (2025) Vol. 14, Iss. 1
Closed Access
Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease
Yan Jin, Mei Nie, Hang Zhang, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 9
Closed Access
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease
Wenqian Wang, Wenfu Cao, Shenyun Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1996-1996
Open Access
Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada
Mariam Narous, Zoann Nugent, Inna Rabinovich-Nikitin, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e097687-e097687
Open Access
Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases
G. Lukina, О. В. Князев, E. А. Belousova, et al.
Terapevticheskii arkhiv (2025) Vol. 97, Iss. 2, pp. 198-213
Open Access
Dual-targeted Therapy for the Management of Refractory Crohn’s Disease: A Retrospective Cohort Study
Jindan He, Jiaqi Zhang, He Zhou, et al.
Research Square (Research Square) (2025)
Closed Access
New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative Review
Valeria Dipasquale, Claudio Romano
Healthcare (2025) Vol. 13, Iss. 8, pp. 923-923
Open Access
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
Stefan Schreiber, Jean‐Frédéric Colombel, Stephen B. Hanauer, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
Antimicrobial, anti-inflammatory, and anticancer potential of green synthesis TiO2 nanoparticles using Sophora flavescens root extract
Mouhaned Y. Al-darwesh, Karukh Ali Babakr, İbrahim Nazem Qader, et al.
Chemical Papers (2024)
Closed Access | Times Cited: 1
Editor-in-Chief articles of choice and comments from January to June 2024
Andrzej S. Tarnawski
World Journal of Gastroenterology (2024) Vol. 30, Iss. 34, pp. 3875-3882
Closed Access
Exploring intimacy and family planning in Inflammatory Bowel Diseases: a qualitative study
Kristýna Gábová, Hana Bednaříková, Zdeněk Meier, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer
Pengfei Zhang, Bing Pei, Chengxue Yi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 2, pp. 167578-167578
Closed Access
New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease
Wenting Xie, Huixia Yang, Lan Bai, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 5
Closed Access
Page 1

Scroll to top